A clinical evaluation of severity and management of peri-implantitis around dental implant in post COVID 19 patients- Randomized control trial - NI

Council of Science and Technology U P0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•Post covid-19 healthy subjects will be recruited who have SPO2, Pulse rate, Blood pressure within standard limits.
•Ability to understand the procedure and provide informed consent assessed by decision making capacity and approaches before being included in the study.
•Diagnosis of peri-implantitis based on the soft tissue around the implant showing obvious inflammatory symptoms, bone loss revealed by X-ray examination and probable haemorrhage and suppuration.
•At least 2 implant site with periodontal PD =4- 6 mm.
•Plaque Index around the implant = 2 points
•Visible bleeding around the implant after probing.
•CAL = 3 mm.

•Current smoking habit with moderate or heavy smoking (more than 10 cigarettes per day) or chewing tobacco.
•History of drug abuse or alcoholism within the past 5 years
•Severe bruxism or clenching habit.
•Significant untreated periodontal disease (grade III or IV), caries, or clinical or radiographic signs of infection within two adjacent tooth positions of implant area.
•History of systemic disease that precludes standard dental implant therapy.
•Past history of implant repair and failure over past 6 months.

发起方

Council of Science and Technology U P